Ohr Pharmaceutical Provides Update to Shareholders on 2012 ...

News | 27 December 2012

27, 2012 /PRNewswire/ -- Ohr Pharmaceutical Inc., a pharmaceutical company dedicated to the clinical development of new drugs for underserved therapeutic needs in large and growing markets, announced today that it has published a letter to shareholders ...

Click on the link to read the full article at PR Newswire (press release)
(This link will open in a new window)